"BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.? Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive." Scope of the Report: This report focuses on the BCG Vaccine in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Merck Sanofi Pasteur Japan BCG Lab China National Biotec Serum Institute of India Intervax GSBPL Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers Immune BCG Therapy BCG Market Segment by Applications, can be divided into Hospitals Clinics Others There are 17 Chapters to deeply display the Europe BCG Vaccine market. Chapter 1, to describe BCG Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of BCG Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of BCG Vaccine, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, BCG Vaccine market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe BCG Vaccine sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe BCG Vaccine Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 BCG Vaccine Introduction 1.2 Market Analysis by Type 1.2.1 Immune BCG 1.2.2 Therapy BCG 1.3 Market Analysis by Applications 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Others 1.4 Market Analysis by Countries 1.4.1 Germany Status and Prospect (2012-2022) 1.4.2 France Status and Prospe
